Anti-VEGF therapy transiently normalizes immature tumor vessel structure and improves vessel function; therefore, drug delivery is improved and radiotherapy efficacy is better from oxygenation of the tumor tissue where blood perfusion is induced [56]. Here, VEGFA is linked to neoplasm.